Liangfu Lu

Dr. Liangfu Lu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Pattern Recognition Letters
Verified
Journal Article
Closed access
YMYang Mu
Yang Mu
PWPing Wang
Ping Wang
LLLiangfu Lu
Liangfu Lu
XZXuyun Zhang
Xuyun Zhang
LQLianyong Qi
Lianyong Qi

12 June 2023 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
LLLiangfu Lu
Liangfu Lu
XCXudong Cui
Xudong Cui
Zhiyuan TanZhiyuan Tan
Zhiyuan Tan
YWYulei Wu
Yulei Wu
In the medical research domain, limited data and high annotation costs have made efficient classification under few-shot conditions a popular research area. This paper proposes a meta-learning framework, termed MedOptNet, for few-shot medical image classification. The framework enables the use of various high-performance convex optimization models as classifiers, such as multi-class kernel support vector machines, ridge regression, and other models. End-to-end training is then implemented using dual problems and differentiation in the paper. Additionally, various regularization techniques are employed to enhance the model's generalization capabilities. Experiments on the BreakHis, ISIC2018, and Pap smear medical few-shot datasets demonstrate that the MedOptNet framework outperforms benchmark models. Moreover, the model training time is also compared to prove its effectiveness in the paper, and an ablation study is conducted to validate the effectiveness of each module.

20 September 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
TLTianhao Li
Tianhao Li
HHHonghong Huang
Honghong Huang
SZShuocun Zhang
Shuocun Zhang
YZYongdan Zhang
Yongdan Zhang
HJHaoren Jing
Haoren Jing
MZMingqing Zhang
Mingqing Zhang
Background: This study aimed to develop an artificial intelligence predictive model for predicting the probability of developing BM in CRC patients.Methods: From SEER database, 50,566 CRC patients were identified between January 2015 and December 2019 without missing data. SVM and LR models were trained and tested on the dataset. Accuracy, area under the curve (AUC), and IDI were used to evaluate and compare the models.Results: For bone metastases in the entire cohort, SVM model with poly as kernel function presents the best performance, whose accuracy is 0.908, recall is 0.838, and AUC is 0.926, outperforming LR model. The top three most important factors affecting the model's prediction of BM include extraosseous metastases (EM), CEA, and size.Conclusion: Our study developed an SVM model with poly as kernel function for predicting BM in CRC patients. SVM model could improve personalized clinical decision-making, help rationalize the bone metastasis screening process, and reduce the burden on healthcare systems and patients.

23 August 2023 in Cancer Medicine
Verified
Journal Article
Open access
JZJingyue Zhang
Jingyue Zhang
XCXudong Cui
Xudong Cui
CYChong Yang
Chong Yang
DZDiansheng Zhong
Diansheng Zhong
YSYinjuan Sun
Yinjuan Sun
HYHengjie Yuan
Hengjie Yuan
Objective: This study aims to develop a risk prediction model for chemotherapy‐induced nausea and vomiting (CINV) in cancer patients receiving highly emetogenic chemotherapy (HEC) and identify the variables that have the most significant impact on prediction.Methods: Data from Tianjin Medical University General Hospital were collected and subjected to stepwise data preprocessing. Deep learning algorithms, including deep forest, and typical machine learning algorithms such as support vector machine (SVM), categorical boosting (CatBoost), random forest, decision tree, and neural network were used to develop the prediction model. After training the model and conducting hyperparameter optimization (HPO) through cross‐validation in the training set, the performance was evaluated using the test set. Shapley additive explanations (SHAP), partial dependence plot (PDP), and Local Interpretable Model‐Agnostic Explanations (LIME) techniques were employed to explain the optimal model. Model performance was assessed using AUC, F1 score, accuracy, specificity, sensitivity, and Brier score.Results: The deep forest model exhibited good discrimination, outperforming typical machine learning models, with an AUC of 0.850 (95%CI, 0.780–0.919), an F1 score of 0.757, an accuracy of 0.852, a specificity of 0.863, a sensitivity of 0.784, and a Brier score of 0.082. The top five important features in the model were creatinine clearance (Ccr), age, gender, anticipatory nausea and vomiting, and antiemetic regimen. Among these, Ccr had the most significant predictive value. The risk of CINV decreased with increased Ccr and age, while it was higher in the presence of anticipatory nausea and vomiting, female gender, and non‐standard antiemetic regimen.Conclusion: The deep forest model demonstrated good discrimination in predicting the risk of CINV in cancer patients prescribed HEC. Kidney function, as represented by Ccr, played a crucial role in the model's prediction. The clinical application of this predictive tool can help assess individual risks and improve patient care by proactively optimizing the use of antiemetics in cancer patients receiving HEC.

18 June 2019 in Computational Intelligence
Verified
Journal Article
Closed access
PDF file
RJRize Jin
Rize Jin
LLLiangfu Lu
Liangfu Lu
JLJoomin Lee
Joomin Lee
AUAnwar Usman
Anwar Usman

30 March 2014 in Nonlinear Dynamics
Verified
Journal Article
Closed access
PDF file
YZYongxiang Zhang
Yongxiang Zhang
LLLiangfu Lu
Liangfu Lu